valsartan and amlodipine

DRUG3 trials

Sponsors

Novartis, Novartis Pharmaceuticals, Shiraz University of Medical Sciences

Conditions

Hypertension

Phase 4

The Effects of Moderate vs. Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) Monotherapy

CompletedNCT00666536

NovartisHypertension

Start: 2008-03-31Updated: 2016-10-27

Valsartan Intensified Primary Care Reduction of Blood Pressure Study

CompletedNCT00902304

Novartis PharmaceuticalsHypertension

Start: 2009-07-31End: 2011-07-31Updated: 2012-12-04

Comparing Bisoprolol and Valsartan-Amlodipine for Hypertension

CompletedNCT07327749

Shiraz University of Medical SciencesHypertension

Start: 2022-10-01End: 2025-12-12Updated: 2026-01-08